RE: SUP Valuation6 Jul 2022 19:25
Hi, thanks for this and to Rooba for the comments on the other thread. I though the call was reassuring and the explanation on lighting plausible and the vaping stuff is still exciting as a growth prospect. I also wouldn't be surprised to see some director buys.
I'm still working through all the numbers, but what I reckon so far is:
Before the RNS, we knew what 2022 was going to be and the RNS just confirms that. Before the RNS, the SP was, let's say, 125p - which takes account of all the macro problems etc etc. Given that the 2022 numbers are basically the same before and after the RNS it doesn't help valuation of the SP drop, instead I compare 2023E using Equity Development's numbers. EPS before was 13.3 and is now 9.3: using before SP of 125 and after SP of, say, 80 that gives PE of 9.4 before and 8.6 after. If you look at it in terms of 2023 div yield, 5.84% becomes 5.87%; earnings yield goes from 10.64 to 11.625 and div cover from 1.82 to 1.97. So it has got cheaper on these measures, but not by a lot. The div numbers from ED also seem to include the final div from 2022 in 2023, which isn't very helpful, as that keeps the payout ratio at 50% for FY23, but we know it's going to 25% - hence 2024 is a div of 2.6p with EPS of 11.7. So based on all this, my impression so far is that the drop is basically about right (assuming that the SP before the drop was about right). However, I'd love to be told that there is something in the RNS that I've missed that puts a better gloss on things because I have a position in this already and would obviously like a SP rise from here!